Companies › Celldex Therapeutics
2 active drug programs in 6 registered trials: 3 Phase 3, 2 Phase 2, 1 Phase 1; Immunology, Respiratory; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Barzolvolimab Anti-filaggrin monoclonal antibody | FLG | Phase 3 | Chronic Spontaneous Urticaria; Chronic Inducible Urticaria; Atopic Dermatitis; Prurigo Nodularis | Dec 2026 |
| CDX-622 | – | Phase 1 | Mild to Moderate Asthma | Mar 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT06727552 | Barzolvolimab | Phase 2 | Atopic Dermatitis | Immunology | Dec 2026 |
| NCT06366750 | Barzolvolimab | Phase 2 | Prurigo Nodularis | Immunology | Mar 2027 |
| NCT07330778 | CDX-622 | Phase 1 | Mild to Moderate Asthma | Respiratory | Mar 2027 |
| NCT06445023 | Barzolvolimab | Phase 3 | Chronic Spontaneous Urticaria | Immunology | Apr 2027 |
| NCT06455202 | Barzolvolimab | Phase 3 | Chronic Spontaneous Urticaria | Immunology | Apr 2027 |
| NCT07266402 | Barzolvolimab | Phase 3 | Chronic Inducible Urticaria | Immunology | Jun 2028 |
Cash and short-term investments of $650m on 2026-09-30; operating cash outflow about $252m a year; runway about 31 months at that burn, to Apr 2029; 5 of 5 coming phase 2-3 readouts fall inside that runway
Press releases filed as 8-K in the last year:
Held by 13 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.
–
Shanghai Mabgeek Biotech.Co.Ltd Enanta Pharmaceuticals Syndax Pharmaceuticals Sagimet Biosciences Avalyn Pharma
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.